91.15

1.32% -1.22

Guardant Health Inc (GH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché GH Giù? Forum Previsione

Precedente Chiudi:

$92.37

Aprire:

$96.3

Volume 24 ore:

1.65M

Relative Volume:

0.85

Capitalizzazione di mercato:

$11.96B

Reddito:

$982.02M

Utile/perdita netta:

$-416.28M

Rapporto P/E:

-27.50

EPS:

-3.3148

Flusso di cassa netto:

$-233.07M

1 W Prestazione:

+5.28%

1M Prestazione:

-2.93%

6M Prestazione:

+45.49%

1 anno Prestazione:

+114.62%

Intervallo 1D:

$90.93

$96.30

Intervallo di 1 settimana:

$83.45

$96.30

Portata 52W:

$36.36

$120.74

Guardant Health Inc Stock (GH) Company Profile

Nome

Guardant Health Inc

Settore

Healthcare (1116)

Industria

Diagnostics & Research (52)

Telefono

855-698-8887

Indirizzo

3100 HANOVER STREET, PALO ALTO

Dipendente

2,506

Cinguettio

@guardanthealth

Prossima data di guadagno

2026-02-19

Ultimi documenti SEC

GH's Discussions on Twitter

Compare GH vs TMO, DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GH Guardant Health Inc	91.15	12.12B	982.02M	-416.28M	-233.07M	-3.3148
TMO Thermo Fisher Scientific Inc	494.54	182.60B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	190.79	134.18B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	564.66	44.63B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	114.54	32.21B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	299.89	29.21B	3.17B	642.63M	516.49M	10.77

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-20	Reiterato	Canaccord Genuity	Buy
2026-02-17	Iniziato	Robert W. Baird	Outperform
2026-01-05	Downgrade	Evercore ISI	Outperform → In-line
2025-12-02	Ripresa	Morgan Stanley	Overweight
2025-09-25	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2025-09-22	Ripresa	Wells Fargo	Overweight
2025-04-10	Iniziato	Mizuho	Outperform
2025-01-23	Iniziato	Barclays	Overweight
2024-06-28	Aggiornamento	Guggenheim	Neutral → Buy
2024-06-03	Ripresa	Jefferies	Buy
2024-04-24	Ripresa	Craig Hallum	Buy
2023-12-14	Iniziato	Guggenheim	Neutral
2023-12-13	Iniziato	Wolfe Research	Peer Perform
2023-11-13	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-09-28	Iniziato	Bernstein	Outperform
2023-09-27	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-07-05	Ripresa	JP Morgan	Overweight
2023-05-26	Aggiornamento	Citigroup	Neutral → Buy
2023-05-05	Iniziato	UBS	Buy
2023-03-09	Downgrade	Citigroup	Buy → Neutral
2023-01-05	Iniziato	Scotiabank	Sector Outperform
2022-11-01	Downgrade	Piper Sandler	Overweight → Neutral
2022-10-19	Iniziato	Craig Hallum	Buy
2022-10-06	Iniziato	Stephens	Overweight
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-06-03	Iniziato	Piper Sandler	Overweight
2022-04-28	Ripresa	BTIG Research	Buy
2022-02-24	Reiterato	Canaccord Genuity	Buy
2022-02-24	Reiterato	Citigroup	Buy
2022-02-24	Reiterato	Cowen	Outperform
2022-02-24	Reiterato	Morgan Stanley	Overweight
2022-02-24	Reiterato	SVB Leerink	Outperform
2022-02-24	Reiterato	Stifel	Buy
2022-02-24	Reiterato	Wells Fargo	Overweight
2021-10-15	Ripresa	Cowen	Outperform
2021-06-15	Iniziato	Raymond James	Mkt Perform
2021-06-03	Iniziato	Goldman	Buy
2021-05-25	Iniziato	Wells Fargo	Overweight
2021-01-11	Iniziato	Stifel	Buy
2020-09-09	Iniziato	Morgan Stanley	Overweight
2020-06-12	Iniziato	BTIG Research	Buy
2020-02-21	Iniziato	Guggenheim	Buy
2020-01-07	Iniziato	Citigroup	Buy
2019-08-07	Reiterato	Canaccord Genuity	Buy
2019-04-16	Iniziato	Canaccord Genuity	Buy
2019-04-10	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-02-28	Reiterato	BofA/Merrill	Neutral
2018-10-29	Iniziato	BofA/Merrill	Neutral
2018-10-29	Iniziato	JP Morgan	Overweight
2018-10-29	Iniziato	William Blair	Outperform

Mostra tutto

Guardant Health Inc Borsa (GH) Ultime notizie

Apr 01, 2026

Guardant Health Stock Rises on Japan Regulatory News for Daiichi Sankyo DrugNews and Statistics - IndexBox

Apr 01, 2026

Director at Guardant Health (GH) acquires 155 shares via RSUs - Stock Titan

Apr 01, 2026

Quarterly Recap: Can Guardant Health Inc maintain its current growth rate2026 Institutional Moves & Smart Allocation Stock Reports - baoquankhu1.vn

Apr 01, 2026

Guardant Health (GH) Gains Momentum on Promising Outlook - GuruFocus

Apr 01, 2026

Guardant Health gets oncology innovation accolade at Healthcare Asia Medtech Awards 2026 - Mugglehead Magazine

Apr 01, 2026

Mar 31, 2026

Why Is Guardant Health (GH) Stock Soaring Today - Yahoo Finance

Mar 31, 2026

Guardant Health (GH) partners with Manulife to launch Shield multi-cancer detection test in Asia - MSN

Mar 31, 2026

Guardant Health (GH) and Verana Health Announces New Partnership - Insider Monkey

Mar 31, 2026

INVESCO Small Cap Equity Fund's Guardant Health Inc(GH) Holding History - GuruFocus

Mar 31, 2026

Guardant Health real-world data supports Japan approval of ENHERTU for HER2-positive tumors - MSN

Mar 31, 2026

Mar 30, 2026

The Bull Case For Guardant Health (GH) Could Change Following Japan’s ENHERTU Approval Using Its AI Data - simplywall.st

Mar 30, 2026

Guardant Health's Infinityai real-world evidence supports approval of Enhertu® for previously treated patients with HER2-positive metastatic solid tumors in Japan - MarketScreener

Mar 30, 2026

Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan - Business Wire

Mar 30, 2026

Liquid Biopsy Market Is Booming Rapidly with Strong Demand By 2033 | Guardant Health Inc., Foundation Medicine Inc. - openPR.com

Mar 30, 2026

Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook - GlobeNewswire Inc.

Mar 30, 2026

(GH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Mar 30, 2026

Mar 29, 2026

5 High Growth Healthcare Stocks to Buy Now - Insider Monkey

Mar 29, 2026

GH PE Ratio & Valuation, Is GH Overvalued - intellectia.ai

Mar 29, 2026

Guardant Health to present new cancer research while stock trades lower amid strong sell signals - Traders Union

Mar 29, 2026

Guardant Health Shares Fall as Market Reacts to Conflict, Policy Deadlines | 2026News and Statistics - IndexBox

Mar 29, 2026

Mar 27, 2026

Why Guardant Health (GH) Stock Is Falling Today - Yahoo Finance

Mar 27, 2026

Vanguard disaggregates holdings; reports 0% of Guardant Health (GH) - Stock Titan

Mar 27, 2026

GH Stock Price, Quote & Chart | GUARDANT HEALTH INC (NASDAQ:GH) - ChartMill

Mar 27, 2026

Mar 26, 2026

Guardant Health wins at Healthcare Asia Medtech Awards 2026 - healthcareasiamagazine.com

Mar 26, 2026

Tempus AI Reinforces Market Position With Collaborations in 2026 - TradingView

Mar 26, 2026

Mar 24, 2026

Guardant Health Ignites 5.6% Surge: A Volatile Breakout or a Trap for the Unwary? - Bitget

Mar 24, 2026

Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data - Lelezard

Mar 24, 2026

Verana and Guardant’s RWE Stack Aims to Solve Precision Oncology’s Data Challenges—Driving Growth Through Recurring Revenue and Broader Data Collections - Bitget

Mar 24, 2026

Mar 23, 2026

Guardant Health Manulife Shield Partnership Highlights Asia Growth And Valuation Gap - Yahoo Finance

Mar 23, 2026

Guardant Health (GH) director’s RSU vesting adds 264 common shares - Stock Titan

Mar 23, 2026

How Guardant’s Shield Blood Test Rollout Through Quest Diagnostics (DGX) Has Changed Its Investment Story - Yahoo Finance

Mar 23, 2026

Mar 21, 2026

GH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 21, 2026

Multiple analysts lift Guardant Health, Inc. (GH) targets on screening and data growth - MSN

Mar 21, 2026

Insiders Shake Up Guardant, Ovintiv, Redwire, Builders FirstSource, Permian - TipRanks

Mar 21, 2026

Mar 20, 2026

Why Guardant Health’s (GH) 2026 screening story reinforced Piper Sandler’s bullish view - MSN

Mar 20, 2026

Guardant Health (GH) Partners With Manulife to Launch Shield Multi-Cancer Detection Test in Asia - Insider Monkey

Mar 20, 2026

Guardant Health to present 28 abstracts on multiomic cancer research at AACR26 - Traders Union

Mar 20, 2026